Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application

Mesenchymal stromal cell (MSC)-based therapy holds great promise for treating immune disorders and for regenerative medicine in agreement with their paracrine trophic and immunosuppressive activities. Various processes have been developed worldwide to produce clinical grade MSCs but, so far, it is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ménard, Cédric, Tarte, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706914/
https://www.ncbi.nlm.nih.gov/pubmed/23742637
http://dx.doi.org/10.1186/scrt214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706914/
https://www.ncbi.nlm.nih.gov/pubmed/23742637
http://dx.doi.org/10.1186/scrt214

Ejemplares similares